A latest report has been added to the wide database of Neuromodulation Market by Infinium Global Research. This report
studies the Neuromodulation Market by technology (deep brain, spinal cord, gastric, sacral, vagus nerve stimulation),
application (chronic pain, parkinson’s disease, dystonia, essential tremor, gastroparesis, OCD, refractory epilepsy, TRD, urinary
fecal incontinence) market status and outlook of global and major regions, from manufacturers, and end industries. The
objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values
for the next six years. Neuromodulation Market provides opportunities in micro markets for stakeholders to invest along with
the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the
Neuromodulation Market
Get a Sample Request: https://www.infiniumglobalresearch.com/reports/sample_request/149
Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous
system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous systems,
the autonomic nervous system, and the deep cell nuclei of the brain, resulting in modulation of their activity.
Neuromodulation includes several modalities, and is a cross-disciplinary approach to pain control and neurologic dysfunction.
Neuromodulation can be used to treat movement disorders, spasticity, and epilepsy, as well as pain syndromes. Devices are
implanted which can either include drug delivery pumps or neural stimulators. The most common type is spinal cord
stimulation, which is used for back or lower extremity pain. Spinal cord stimulation involves electrical stimulation of the spinal
cord to interrupt pain signals from the spinal cord to the brain, and to trade a painful sensation with a more pleasant tingling
sensation. The technology has been present since the 1960s and in the past decade has become highly effective in the
treatment of pain. In addition to chronic pain relief, other neuromodulation treatments now used include deep brain
stimulation for essential tremor, Parkinson’s disease, dystonia, epilepsy and disorders such as depression, obsessive
compulsive disorder and Tourette syndrome; sacral nerve stimulation for pelvic disorders and incontinence; gastric and
colonic stimulation for gastrointestinal disorders such as dysmotility or obesity; vagus nerve stimulation for epilepsy, obesity
or depression; carotid artery stimulation for hypertension; and spinal cord stimulation for ischemic disease such as angina and
peripheral vascular disease.
Infinium Global Research